Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03575598 | Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study(SNOW) | completed | Early Phase 1 | 10 | University Health Network, TorontoOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05888675 | Clinical Study of Weifuchun Treatment on Gastric Cancer | completed | Early Phase 1 | 72 | ShuGuang HospitalOTHER | 0 | Jul 25, 2023 | clinicaltrials |
| NCT03599453 | Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer | completed | Early Phase 1 | 8 | Roswell Park Cancer InstituteOTHER | 1 | Jul 18, 2023 | clinicaltrials |
| NCT02538484 | Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects | completed | Early Phase 1 | 24 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT03122444 | Imipramine on ER+ve and Triple Negative Breast Cancer | completed | Early Phase 1 | 17 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03360708 | Vaccine Therapy in Treating Patients With Recurrent Glioblastoma | completed | Early Phase 1 | 20 | Mayo ClinicOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03402230 | Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers | completed | Early Phase 1 | 49 | National Cancer Institute (NCI)NIH | 1 | Jun 28, 2023 | clinicaltrials |
| NCT02391025 | Gallium-68 Citrate PET Used in Prostate Cancer | completed | Early Phase 1 | 39 | Rahul AggarwalOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT05908838 | Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer | completed | Early Phase 1 | 146 | ShuGuang HospitalOTHER | 0 | Jun 18, 2023 | clinicaltrials |
| NCT04484532 | Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers | completed | Early Phase 1 | 130 | Roswell Park Cancer InstituteOTHER | 1 | Jun 6, 2023 | clinicaltrials |
| NCT03282461 | A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery | completed | Early Phase 1 | 12 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT04857697 | Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer | completed | Early Phase 1 | 6 | Mayo ClinicOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT03927651 | ICG to Assess Ovarian Perfusion | completed | Early Phase 1 | 54 | Northwestern UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04158817 | 68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage | completed | Early Phase 1 | 8 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04040686 | HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02 | completed | Early Phase 1 | 10 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05126927 | A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors | completed | Early Phase 1 | 11 | SmartNuclide BiopharmaINDUSTRY | 1 | Apr 12, 2023 | clinicaltrials |
| NCT04282967 | Streaming Web-based Exercise At Home: A Pilot Study | completed | Early Phase 1 | 12 | Celina ShirazipourOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT04976257 | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | completed | Early Phase 1 | 5 | Ryan Kohlbrenner, MDOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT04041128 | PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer | completed | Early Phase 1 | 14 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT03250520 | Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca | completed | Early Phase 1 | 8 | Hospital Infantil de Mexico Federico GomezOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT02534376 | Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal | completed | Early Phase 1 | 63 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02683200 | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer | completed | Early Phase 1 | 21 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05728515 | A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma | completed | Early Phase 1 | 3 | Peking Union Medical College HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT04518345 | TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia | completed | Early Phase 1 | 3 | Uma BorateOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT03411070 | SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer | completed | Early Phase 1 | 27 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT02826382 | Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 | completed | Early Phase 1 | 14 | Five Eleven Pharma, Inc.INDUSTRY | 1 | Jan 12, 2023 | clinicaltrials |
| NCT03281811 | Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides | completed | Early Phase 1 | 11 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT03407716 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT04114370 | Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma(FACBC) | completed | Early Phase 1 | 9 | James MountzOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT02851056 | Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) | completed | Early Phase 1 | 14 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT02405078 | Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | completed | Early Phase 1 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT04797728 | Elacestrant in Preoperative Setting, a Window of Opportunity Study(ELIPSE) | completed | Early Phase 1 | 23 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT04130152 | Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy(PROMETEO II) | completed | Early Phase 1 | 22 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT02065609 | 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography | completed | Early Phase 1 | 52 | Washington University School of MedicineOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT02072356 | Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery | completed | Early Phase 1 | 290 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT03858491 | Pharmacokinetic Boosting of Osimertinib(OSIBOOST) | completed | Early Phase 1 | 11 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT04267900 | 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer | completed | Early Phase 1 | 34 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT00962845 | Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | completed | Early Phase 1 | 20 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT03020017 | NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery | completed | Early Phase 1 | 8 | Northwestern UniversityOTHER | 1 | Aug 26, 2022 | clinicaltrials |
| NCT03655756 | pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma | completed | Early Phase 1 | 7 | TuHURA Biosciences, Inc.INDUSTRY | 1 | Aug 8, 2022 | clinicaltrials |
| NCT00978562 | DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors | completed | Early Phase 1 | 14 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04019834 | Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy(RELIEF) | completed | Early Phase 1 | 21 | University of Alabama at BirminghamOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04065555 | Intratumoral Microdosing of TAK-981 in Head and Neck Cancer | completed | Early Phase 1 | 12 | Presage BiosciencesINDUSTRY | 1 | Jul 29, 2022 | clinicaltrials |
| NCT01781741 | Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer | completed | Early Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT02885272 | FDG PET Imaging in Diagnosing Patients With Glioblastoma | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT03982407 | 68 Ga PSMA PET/MRI for Hepatocellular Carcinoma | completed | Early Phase 1 | 5 | Ajit H. Goenka, MDOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT02626130 | Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer | completed | Early Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT02046694 | A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | completed | Early Phase 1 | 34 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04936997 | Immune Response to the COVID-19 Vaccine | completed | Early Phase 1 | 20 | University of ArizonaOTHER | 1 | May 20, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jul 27, 2023source: clinicaltrials